文档介绍:PPARγ激活对糖基化终末产物引起的大鼠肾系膜细胞TGFβ及CTGF mRNA表达的影响
(作者:___________单位: ___________邮编: ___________)
作者:刘辉于晓艳魏海峰石艳苗春生李才邹颖刚
【摘要】目的观察过氧化物酶体增殖体激活受体γ(PPARγ)激活对糖基化终末产物(AGEs)引起的大鼠肾系膜细胞TGFβ及CTGF mRNA表达的影响。方法体外培养正常大鼠肾系膜细胞,逆转录聚合酶链式反应(RTPCR)检测不同浓度AGEs(0~400 μg/ml1)及不同浓度PPAPγ)激活剂(罗格列酮)和PPARγ阻断剂(GW9662)对AGEs(100 μg/ml-1)引起的TGFβ及CTGF mRNA表达的影响。结果给予PPARγ激活剂可明显减轻AGEs引起的大鼠系膜细胞TGFβ、CTGF mRNA的表达。结论 PPARγ激活剂可以明显减轻AGEs对系膜细胞TGFβ、CTGF mRNA的表达影响,从而改善肾小球细胞外基质积聚,在糖尿病时起到肾脏保护作用。
【关键词】过氧化物酶体增殖体激活受体γ;糖尿病肾病; 糖基化终末产物;转化生长因子β;结缔组织生长因子
【Abstract】 Objective To investigate the role of peroxisome proliferator
activated receptor(PPAR)γ activation on the expressions of TGFβ and CTGF mRNA in rat mesangial cells extenuation induced by advanced glycation end products (AGEs). Methods Rat mesangial cells were treated with AGEmodified bovine serum albumin or native bovine serum albumin. Normal mesangial cells without any treatments were as control. TGFβ and CTGF mRNA were analyzed by reverse transcriptasepolymerase chain reaction (RTPCR). The expressions of TGFβ and CTGF mRNA in mesangial cell induced by rosiglitazone (0~10 μmol/L) and the inhibitor of PPARγ(10 μmol/L) were tested with RTPCR. Results PPARγ activation relieved TGFβ and CTGF mRNA expressing induced by AGEs(0~400 mg/L) in mesangial cells. Conclusions PPARγ activation can relieve the expressions of TGFβ and CTGF mRNA in rat mesangial cells induced by AGEs,suggesting that PPARγ activation has a kidney protection in diabetic mellitus through ameliorating extracellular matrix accumulation.
【Key words】 Peroxisome proliferator activated receptorγ; Diabetic nephropathies; Glycosylation end products, Advanced; TGFβ;CTGF
糖尿病肾病(DN)的发病机制是以高血糖为启动因素所诱导的各种血管活性物质、生长因子、细胞介质等综合作用的结果,其中转化生长因子
β(TGFβ)和结缔组织生长因子(CTGF)的作用尤其受到关注。持续高血糖状态下体内蛋白质能发生一系列非酶促糖基化反应,最后形成的糖基化终末产物(AGEs)在DN发生机制中具有重要意义〔1〕,AGEs可诱导TGFβ和CTGF等基因表达异常。过氧化物酶体增殖体激活受体γ(PPARγ)是核内受体转录因子超家族成员之一,在脂肪生成、胰岛素敏感性、细胞周期调节及细胞分化中起重要作用,抗糖尿病药物胰岛素增敏剂四氢噻唑烷二酮类药物(TZDs)如罗格列酮(Rosiglitazo